This brochure is intended to explain the subcutaneous treatment with HyQvia® to your patients in more detail and support during therapy. Here your patients will find valuable tips and guidance for their illness and the subcutaneous immunoglobulin administration.

Here you will find information and contact details of our customer service.

Primary immunodeficiency diseases (PIDD) are a group of more than 430 rare, chronic disorders where part of the immune system is missing or not functioning properly.^1,2

Patients with immunodeficiencies or coagulation disorders rely on therapeutics that are based on human blood plasma. It takes months for a donation to become a life-saving therapeutic.

With the ID+ APP*, we have developed an electronic alternative to the infusion/ infection diary. A practical option for easily recording the necessary information.

In a short guide we explain how to administer the subcutaneous immunoglobulin Cuvitru® and which characteristics this application form of therapy entails. In a special chapter we have compiled common questions and answers about immunoglobulin therapy for you.

The travel journal helps your patients to prepare well for their travels.